TFF3 and PVRL2 co-targeting identified by multi-omics approach as an effective cancer immunosuppression strategy
PVRL2 has emerged as a promising immunoinhibitory target with significant associations with TFF3 and represents a key co-targetable molecule for effective oncotherapeutic strategies.
Authors
- Tesfaye Wolde (ORCID: https://orcid.org/0000-0002-6856-8829)
- Peng Huang (ORCID: https://orcid.org/0000-0003-0620-0911)
- Vipul Bhardwaj (ORCID: https://orcid.org/0000-0001-5509-8840)
- Xi Zhang (ORCID: https://orcid.org/0000-0003-4093-0897)
- Vijay Pandey
Institutions
- University Town of Shenzhen (CN)
- Shenzhen Bay Laboratory (CN)
- Tsinghua–Berkeley Shenzhen Institute (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Life Sciences
- Published
- 2024-10-05
- DOI
- https://doi.org/10.1016/j.lfs.2024.123113
- Citations
- 4
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.94